Vanberra Signal

ViCardio

Curated by Signal

Wrist-worn blood pressure monitoring device

Overview

ViCardio, the consumer division of Tarilian Laser Technologies, offers a wrist-worn blood pressure monitor. It features a proprietary patented optoelectronic sensor that detects biological signals to monitor blood pressure. The blood pressure monitor delivers a beat to beat blood pressure reading thereby enabling the measurement of the overall health of the heart and the circulatory system. The company claims that the blood pressure readings using the device result in less deviation in mercury, coming in at 2.8mm versus the 4.5mm, using the cuff. It works in integration with a companion application that is compatible with both Android and iOS devices. The product is slated to be launched and available for clinicians and consumers in Q4 of 2018, on receiving CE/FDA clearance.

Key facts

Founded
2017

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Hypoglycemia Symptoms Alarm

    Life Sciences TechnologyNorthampton, United Kingdom
  • Developer of optimized drug discovery and design services

    Life Sciences TechnologyManchester, United Kingdom
  • Developer of small molecular therapeutics for multiple disorders

    Life Sciences TechnologyLondon, United Kingdom

About ViCardio

What does ViCardio do?

ViCardio, the consumer division of Tarilian Laser Technologies, offers a wrist-worn blood pressure monitor.

Where is ViCardio headquartered?

ViCardio is headquartered in Welwyn Garden City, United Kingdom.

When was ViCardio founded?

ViCardio was founded in 2017.

Which sector is ViCardio in?

ViCardio operates in Life Sciences Technology.

Who are ViCardio's competitors?

Companies similar to ViCardio include Medpage, C4X Discovery, and Aptorum Group.